tiprankstipranks
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market
Holding AQST?
Track your performance easily

Aquestive Therapeutics (AQST) Financial Statements

2,078 Followers

Aquestive Therapeutics Financial Overview

Aquestive Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.449; its P/E ratio is -10.54; Aquestive Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 13.54M$ 20.10M$ 12.05M$ 13.21M$ 13.00M
Gross Profit$ 9.11M$ 15.57M$ 7.66M$ 8.53M$ 8.20M
EBIT$ -11.51M$ 34.00K$ -10.31M$ -4.78M$ -2.17M
EBITDA$ -8.68M$ 2.91M$ -7.43M$ -4.31M$ -1.85M
Net Income Common Stockholders$ -11.51M$ -2.75M$ -12.83M$ -8.11M$ -2.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 77.89M$ 89.87M$ 95.20M$ 0.00$ 24.92M
Total Assets$ 109.96M$ 117.61M$ 129.52M$ 57.42M$ 59.45M
Total Debt$ 24.45M$ 23.19M$ 21.84M$ 33.32M$ 45.04M
Net Debt$ -53.44M$ -66.68M$ -73.36M$ 33.32M$ 20.12M
Total Liabilities$ 155.38M$ 153.08M$ 165.82M$ 163.91M$ 162.38M
Stockholders Equity$ -45.42M$ -35.48M$ -36.30M$ -106.49M$ -102.93M
Cash Flow-
Free Cash Flow$ -11.96M$ -7.04M$ -10.41M$ -4.96M$ -2.50M
Operating Cash Flow$ -11.88M$ -7.01M$ -10.38M$ -4.94M$ -2.35M
Investing Cash Flow$ -80.00K$ -35.00K$ -29.00K$ -16.00K$ -151.00K
Financing Cash Flow$ -17.00K$ 1.71M$ 81.74M$ 3.91M$ 4.98M
Currency in USD

Aquestive Therapeutics Earnings and Revenue History

Aquestive Therapeutics Debt to Assets

Aquestive Therapeutics Cash Flow

Aquestive Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis